Recent advances in transition metal (Pd, Ni)-catalyzed C(sp 3 ) H bond activation with bidentate directing groups
Xinglin Yang(Indiana University School of Medicine), Yu Rao(Soochow University), Gang Shan(Tsinghua University), Liguo Wang(Beijing Tongren Hospital)
Cited by 140
Related Papers
PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|627
PROTAC Technology: Opportunities and Challenges
|ACS Medicinal Chemistry Letters|2020|353
PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
|Cell Research|2018|280
Chemistries of bifunctional PROTAC degraders
|Chemical Society Reviews|2022|270